JD Health Repurchases 2.53 Million Shares for HKD 96.92 Million; Total Buybacks Reach 15.95 Million Under 2025 Mandate

Bulletin Express05-28

JD Health International Inc. reported that on 28 May 2026 it bought back 2.53 million ordinary shares on the Hong Kong Stock Exchange at prices ranging between HKD 38.04 and HKD 40.30, for a total consideration of HKD 96.92 million. All repurchased shares are slated for cancellation.

Including this latest transaction, JD Health has repurchased 15.95 million shares since the 20 June 2025 general mandate took effect, equivalent to 0.50 % of the company’s issued share capital as at the mandate date. The mandate authorises buybacks of up to 320.01 million shares, leaving approximately 304.07 million shares, or 99.50 % of the authorisation, still available.

Issued share capital remained unchanged at 3.21 billion shares between 27 May 2026 and 28 May 2026. Shares bought back from 15 May to 28 May 2026 but not yet cancelled also total 15.95 million.

Under Main Board Rule 10.06(3)(a), JD Health is subject to a moratorium on issuing new shares until 27 June 2026 following the latest repurchase. All repurchases were executed in compliance with Hong Kong Stock Exchange regulations, and the company confirmed no material changes to the April 2025 explanatory statement that accompanied the repurchase mandate.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1180538084?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-28 21:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180538084","market":"hk","top_or_hot":-1,"title":"JD Health Repurchases 2.53 Million Shares for HKD 96.92 Million; Total Buybacks Reach 15.95 Million Under 2025 Mandate","media":"Bulletin Express","content":"<p>JD Health International Inc. reported that on 28 May 2026 it bought back 2.53 million ordinary shares on the Hong Kong Stock Exchange at prices ranging between HKD 38.04 and HKD 40.30, for a total consideration of HKD 96.92 million. All repurchased shares are slated for cancellation.</p>\n<p>Including this latest transaction, JD Health has repurchased 15.95 million shares since the 20 June 2025 general mandate took effect, equivalent to 0.50 % of the company’s issued share capital as at the mandate date. The mandate authorises buybacks of up to 320.01 million shares, leaving approximately 304.07 million shares, or 99.50 % of the authorisation, still available.</p>\n<p>Issued share capital remained unchanged at 3.21 billion shares between 27 May 2026 and 28 May 2026. Shares bought back from 15 May to 28 May 2026 but not yet cancelled also total 15.95 million.</p>\n<p>Under Main Board Rule 10.06(3)(a), JD Health is subject to a moratorium on issuing new shares until 27 June 2026 following the latest repurchase. All repurchases were executed in compliance with Hong Kong Stock Exchange regulations, and the company confirmed no material changes to the April 2025 explanatory statement that accompanied the repurchase mandate.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JD Health Repurchases 2.53 Million Shares for HKD 96.92 Million; Total Buybacks Reach 15.95 Million Under 2025 Mandate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJD Health Repurchases 2.53 Million Shares for HKD 96.92 Million; Total Buybacks Reach 15.95 Million Under 2025 Mandate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-28 21:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>JD Health International Inc. reported that on 28 May 2026 it bought back 2.53 million ordinary shares on the Hong Kong Stock Exchange at prices ranging between HKD 38.04 and HKD 40.30, for a total consideration of HKD 96.92 million. All repurchased shares are slated for cancellation.</p>\n<p>Including this latest transaction, JD Health has repurchased 15.95 million shares since the 20 June 2025 general mandate took effect, equivalent to 0.50 % of the company’s issued share capital as at the mandate date. The mandate authorises buybacks of up to 320.01 million shares, leaving approximately 304.07 million shares, or 99.50 % of the authorisation, still available.</p>\n<p>Issued share capital remained unchanged at 3.21 billion shares between 27 May 2026 and 28 May 2026. Shares bought back from 15 May to 28 May 2026 but not yet cancelled also total 15.95 million.</p>\n<p>Under Main Board Rule 10.06(3)(a), JD Health is subject to a moratorium on issuing new shares until 27 June 2026 following the latest repurchase. All repurchases were executed in compliance with Hong Kong Stock Exchange regulations, and the company confirmed no material changes to the April 2025 explanatory statement that accompanied the repurchase mandate.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06618","symbol_name":"京东健康","start_time":0,"source_url":"","article_id":"1180538084","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180538084","pubTimestamp":1779973391,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"JD Health International Inc. reported that on 28 May 2026 it bought back 2.53 million ordinary shares on the Hong Kong Stock Exchange at prices ranging between HKD 38.04 and HKD 40.30, for a total...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06618":"京东健康"},"translate_title":"京东健康9692万港元回购253万股；2025年授权下回购总额达到1595万笔","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06618":1},"content_text":"JD Health International Inc. reported that on 28 May 2026 it bought back 2.53 million ordinary shares on the Hong Kong Stock Exchange at prices ranging between HKD 38.04 and HKD 40.30, for a total consideration of HKD 96.92 million. All repurchased shares are slated for cancellation.\nIncluding this latest transaction, JD Health has repurchased 15.95 million shares since the 20 June 2025 general mandate took effect, equivalent to 0.50 % of the company’s issued share capital as at the mandate date. The mandate authorises buybacks of up to 320.01 million shares, leaving approximately 304.07 million shares, or 99.50 % of the authorisation, still available.\nIssued share capital remained unchanged at 3.21 billion shares between 27 May 2026 and 28 May 2026. Shares bought back from 15 May to 28 May 2026 but not yet cancelled also total 15.95 million.\nUnder Main Board Rule 10.06(3)(a), JD Health is subject to a moratorium on issuing new shares until 27 June 2026 following the latest repurchase. All repurchases were executed in compliance with Hong Kong Stock Exchange regulations, and the company confirmed no material changes to the April 2025 explanatory statement that accompanied the repurchase mandate.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1180538084","isCrawlerRequest":true}